PEP-Therapy is a Paris-based clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, lead drug candidate, is a pro-apoptotic agent currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback